Advertisement

Oral idasanutlin in patients with polycythemia vera

John Mascarenhas, Min Lu, Heidi Kosiorek, Elizabeth Virtgaym, Lijuan Xia, Lonette Sandy, Ruben Mesa, Bruce Petersen, Noushin Farnoud, Vesna Najfeld, Raajit Rampal, Amylou Dueck and Ronald Hoffman

Article Information

Citation 
vol. 134 no. 6 525-533
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted December 21, 2018
  • Accepted May 30, 2019
  • Published online August 8, 2019.

Article Versions


Contributors 
  • John Mascarenhas, 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Min Lu, 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Heidi Kosiorek, 2Division of Biostatistics, Mayo Clinic, Scottsdale, AZ;
  • Elizabeth Virtgaym, 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Lijuan Xia, 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Lonette Sandy, 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Ruben Mesa, 3Mays Cancer Center, University of Texas at San Antonio, San Antonio, TX;
  • Bruce Petersen, 4Department of Pathology and Tumor Cytogenomics, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Noushin Farnoud, 5Center for Hematologic Malignancies, Memorial Sloan Kettering, New York, NY; and
  • Vesna Najfeld, 4Department of Pathology and Tumor Cytogenomics, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Raajit Rampal, 6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
  • Amylou Dueck, 2Division of Biostatistics, Mayo Clinic, Scottsdale, AZ;
  • Ronald Hoffman, 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output